The Gap Between Medicine and Patients Is Where Lives Are Lost

When Karla Lara received a terminal diagnosis of glioblastoma, the most aggressive form of brain cancer, she had everything that should have mattered: employer-sponsored health insurance, proximity to some of the world’s best cancer centers, and a family willing to fight for her. Yet within months, she was gone. And her family was left asking a question that haunts them still: what if the system had actually told them what was possible?

Karla emigrated from Honduras as a teenager, learned English, put herself through college, and spent her career in education supporting underserved children in Los Angeles. She was 50 years old and had done everything right. But when her brain tumor was discovered during what should have been a routine physical therapy visit, her family found themselves navigating a medical landscape with no map, no guide, and no one whose job it was to ensure they understood their options.

The Silence Between Appointments

What makes this story so painful is how preventable the confusion felt in hindsight. Nobody mentioned clinical trials. Nobody encouraged a second opinion. Nobody told them about tumor treating fields, a noninvasive therapy that has been shown to extend survival in glioblastoma patients. They learned about it too late.

Karla’s daughter Michelle became her mother’s full-time caregiver overnight, managing appointments, medications, and increasingly complex medical decisions while working and trying to hold her own life together. She advocated fiercely for her mother every single day. But advocacy only works when you have information. When you know what questions to ask. When someone in the system bothers to tell you the doors that exist before they quietly close.

When palliative care might have eased Karla’s suffering, nobody offered it. The family had to ask for it themselves, late, after her pain had become unbearable to witness. When they finally reached a top cancer center, they learned her tumor’s location made her ineligible for their primary trial. That possibility had never been mentioned before.

This Is Not an Exceptional Story

What David Robles, Karla’s son-in-law, discovered through his work at OurBrainBank, a nonprofit created by and for families affected by glioblastoma, was that Karla’s experience wasn’t exceptional at all. It was the pattern.

Their survey of glioblastoma patients and caregivers across the country revealed something chilling: two-thirds were never offered a clinical trial. More than half were never encouraged to seek a second opinion. Nearly 9 in 10 were never adequately informed about tumor testing or tissue preservation. Over 70 percent had no meaningful involvement with palliative or hospice care as their loved one was dying.

These aren’t failures of science. The science exists. These are failures of communication, access, and equity, documented not by researchers observing from a distance but by the patients and caregivers who lived them.

Robles makes an important distinction that every person navigating the healthcare system should understand: having scientific resources and having access to care are not the same thing. The gap between them is where lives are quietly lost.

The Work Continues

Four months after Karla died, Michelle became pregnant. Today, Karla’s grandsons live in a home where her memory is woven into everyday moments. A painting of Mirabel from Encanto, Karla’s favorite movie, hangs where the boys can see it. Michelle still carries guilt about not being able to save her mother. But David carries something different: a mission.

He’s dedicated to ensuring the next family doesn’t have to figure it out alone. OurBrainBank collects real-world data not just from clinical settings but from the silence between appointments, after discharge, in every decision a doctor never asked about. The patient’s voice has to become impossible to ignore.

This gap isn’t unique to glioblastoma. Families across all kinds of diseases find themselves handed a diagnosis and left to navigate a system that was never designed to guide them through it. The distance between what research uncovers and what patients actually access can be enormous. When system failures happen in those gaps, they’re often invisible. But they’re never inevitable, and that choice to accept them belongs to all of us.

Source: HuffPost